Main Menu

G1 Therapeutics, Inc.

(NYSE: GTHX)

Rigrodsky Law, P.A. is investigating G1 Therapeutics, Inc. (“G1”) regarding possible breaches of fiduciary duties and other violations of law related to G1’s agreement to be acquired by Pharmacosmos A/S. Under the terms of the agreement, G1 shareholders will receive $ 7.15 per share in cash.

Join This Action

Alternatively, you may upload your transactions using the upload button below or email them to info@rl-legal.com.

Draw your signature below using your mouse* [Clear]

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

Date of signing: 12/21/2024


* Indicates a required field.

Back to Page